AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CAPECITABINE 500 Mg ;

11 registrations across 1 African market— 11 active

Markets with CAPECITABINE 500 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Capecitabine
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Capecitabin sandoz
Film Coated Tablets
🇪🇬EgyptSandoz Egypt pharmaactive
Capecitabin sandoz
Film Coated Tablets
🇪🇬EgyptSandoz Egypt pharmaactive
Xeloda®
Film Coated Tablets
🇪🇬EgyptOnco pharm Egyptactive
Kapetral
Film Coated Tablets
🇪🇬EgyptPharma artactive
Capecitabine Pharmacare 500mg
Film Coated Tablets
🇪🇬EgyptGlobe alliance medicaactive
Capecitabine -Viatris
Film Coated Tablets
🇪🇬EgyptOne Pharma Medicsactive
Xeloda®
Film Coated Tablets
🇪🇬EgyptOnco pharm Egyptactive
Kapetral
Film Coated Tablets
🇪🇬EgyptPharma artactive
Capecitabine Pharmacare 500mg
Film Coated Tablets
🇪🇬EgyptGlobe alliance medicaactive
Capecitabine -Viatris
Film Coated Tablets
🇪🇬EgyptOne Pharma Medicsactive

CAPECITABINE 500 Mg ; in Africa — Regulatory Overview

CAPECITABINE 500 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.